Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
3.750
-0.080 (-2.09%)
At close: Nov 4, 2026, 4:00 PM EST
3.740
-0.010 (-0.27%)
After-hours: Nov 4, 2026, 4:10 PM EST
Camp4 Therapeutics Market Cap
Camp4 Therapeutics has a market cap or net worth of $235.32 million as of November 4, 2026. It is the 19,341st most valuable company in the world and the 3,395th biggest in the United States. Its market cap has increased by 27.40% in one year.
Market Cap
235.32M
Enterprise Value
151.30M
1-Year Change
27.40%
Global Rank
Country Rank
#3,395 United States
Category
ChartMarket Cap Chart
Since the IPO on October 11, 2024, Camp4 Therapeutics's market cap has increased from $208.55M to $235.32M, an increase of 12.84%. That is a compound annual growth rate of 6.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 235.32M | -26.01% |
| Dec 31, 2025 | 318.03M | 202.65% |
| Dec 31, 2024 | 105.08M | -49.61% |
| Oct 11, 2024 | 208.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lexeo Therapeutics | 255.15M |
| Ocugen | 252.71M |
| Clinuvel Pharmaceuticals | 247.78M |
| Fate Therapeutics | 244.43M |
| Abeona Therapeutics | 243.03M |
| Cabaletta Bio | 240.75M |
| InflaRx | 238.74M |
| Immuneering | 238.33M |